| 英文别名 |
cis-Atovaquone;2-[cis-4-(4'-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone;cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone;DTXSID7022629;2-(cis-4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione;Atovaquone, >=98% (HPLC);F18448;2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione;KBio1_001726;1,2-Naphthalenedione, 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-;2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone;SR-05000001438-4;Prestwick0_000534;cis-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione; USP Atovaquone Related Compound A; Atorvastatin EP Impurity B;Mepron (antipneumocystic);2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-naphthalene-1,4-dione;ATOVAQUONE [JAN];NCGC00016961-11;BW-566C-80;ATOVAQUONE [USAN];NCGC00016961-03;Pharmakon1600-01504210;BPBio1_000603;s3079;SW219222-1;Acuvel;DRG-0084;GLXC-02590;Spectrum5_001382;BW 566C-80;NSC-759582;BSPBio_002681;cis-2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone;CCG-220534;AS-12809;HMS2093C10;DivK1c_006782;HSDB 7083;BIDD:GT0849;2-hydroxy-3-[(1r,4r)-4-(4-chlorophenyl)cyclohexyl]-1,4-dihydronaphthalene-1,4-dione;CHEBI:575568;CHEMBL519462;ATOVAQUONE [ORANGE BOOK];MALARONE PEDIATRIC COMPONENT ATOVAQUONE;SR-05000001438-5;566C;KBio2_004791;HMS3369N09;Atovaquone (Atavaquone);starbld0018905;KUCQYCKVKVOKAY-OTVXOJSOSA-N;AB00053222_05;Z2588038997;Atovaquone [USAN:USP:INN:BAN];94015-53-9;SCHEMBL9975229;Y883P1Z2LT;SR-05000001438-2;HMS2235N08;Mepron;SCHEMBL21695;EN300-731648;1,4-Naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-, trans-;Prestwick2_000534;ATOVAQUONE [VANDF];STK636160;SPBio_002468;SR-05000001438;ATOVAQUONE [USP-RS];HMS2096L09;MFCD00889188;Q418179;Atovaquone (JAN/USP/INN);KBio2_007359;ATO & IL-12;AKOS015961933;BSPBio_000547;SpecPlus_000686;2-[trans-4-(p-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone;Spectrum3_000991;566C80;NS00010018;Spectrum_001743;NSC 759582;Spectrum2_001665;BW 566C80;BW-556C-80;DTXCID602629;2-(cis-4-(4-Chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione;SCHEMBL9975142;Atovaquone; 2-[trans-4-(4-Chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione; 566C80;Spectrum4_001117;2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxynaphthoquinone, trans-;2-(TRANS-4-(4-CHLOROPHENYL)CYCLOHEXYL)-3-HYDROXY-1,4-NAPHTHALENEDIONE;Tox21_110714_1;2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1.4-naphthoquinone;UNII-Y883P1Z2LT;3-[4-(4-Chlorophenyl)cyclohexyl]-4-hydroxy-1,2-naphthalenedione;3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione;trans-2-(4-(4-chlorophenyl) cyclohexyl)-3-hydroxynaphthalene-1,4-dione;ATOVAQUONE [USP MONOGRAPH];CRL-8131 & Atovaquone;CAS-95233-18-4;atovacuona;A853147;HMS2089M14;ATOVAQUONE [MI];HMS1569L09;NSC759582;2-[4-(4-chlorophenyl)cyclohexy]-3-hydroxy-1,4-naphthoquinone;MALARONE COMPONENT ATOVAQUONE;2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxynaphth... |